Compile Data Set for Download or QSAR
maximum 50k data
Found 18 Enz. Inhib. hit(s) with all data for assayid = 1 entry = 2735
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377695(US10266496, Example 7)
Affinity DataIC50:  10.9nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377689(US10266496, Example 1)
Affinity DataIC50:  19.6nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377702(US10266496, Example 29)
Affinity DataIC50:  34.6nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377698(US10266496, Example 21)
Affinity DataIC50:  39.5nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377706(US10266496, Example 40)
Affinity DataIC50:  53.6nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377704(US10266496, Example 31)
Affinity DataIC50:  57.8nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377692(US10266496, Example 4)
Affinity DataIC50:  60.4nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377697(US10266496, Example 18)
Affinity DataIC50:  63.3nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377694(US10266496, Example 6)
Affinity DataIC50:  66.2nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377700(US10266496, Example 27)
Affinity DataIC50:  88.8nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377696(US10266496, Example 17)
Affinity DataIC50:  90.2nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377693(US10266496, Example 5)
Affinity DataIC50:  94.8nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377691(US10266496, Example 3)
Affinity DataIC50:  101nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377705(US10266496, Example 33)
Affinity DataIC50:  102nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377701(US10266496, Example 28)
Affinity DataIC50:  146nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377699(US10266496, Example 25)
Affinity DataIC50:  164nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377703(US10266496, Example 30)
Affinity DataIC50:  179nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetXanthine dehydrogenase/oxidase(Homo sapiens (Human))
Sunshine Lake Pharma

US Patent
LigandPNGBDBM377690(US10266496, Example 2)
Affinity DataIC50:  667nMAssay Description:The compound was diluted 2.5 fold with a buffer of 50 mM KH2PO4 to give a series of concentrations from 2000 nM to 0.524 nM. Then the diluted solutio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent